The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
93.847 |
PAR-20-140 |
| Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) |
93.213 |
PAR-20-138 |
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-20-007 |
| Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-21-014 |
| Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed) |
93.865 |
RFA-HD-21-010 |
| Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
93.855, 93.866 |
PAR-20-139 |
| Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-20-006 |
| Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional) |
93.839 |
RFA-HL-21-007 |
| In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
93.121, 93.313, 93.865 |
PAR-20-137 |
| Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC) (R24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-018 |
| Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional) |
93.839 |
RFA-HL-21-009 |
| Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional) |
93.839 |
RFA-HL-21-008 |
| Artificial Intelligence and Technology Collaboratories for Aging Research (P30 Clinical Trial Optional) |
93.866 |
RFA-AG-21-009 |
| NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) |
93.172 |
RFA-HG-20-019 |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396 |
PAR-20-131 |
| Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
93.393 |
PAR-20-136 |
| Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-006 |
| Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
93.393, 93.847 |
PAR-20-134 |
| Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) |
93.855 |
RFA-AI-20-028 |
| Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) |
93.393, 93.847 |
PAR-20-133 |
| Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-019 |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
93.113, 93.142, 93.143, 93.172, 93.213, 93.307, 93.393, 93.394, 93.395, 93.396, 93.399, 93.847, 93.855, 93.859, 93.865 |
PA-20-135 |
| NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed) |
93.846 |
RFA-AR-21-004 |
| Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-015 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) |
93.394, 93.395 |
RFA-CA-20-033 |
| Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-010 |
| Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) |
93.855 |
PAS-20-121 |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) |
93.173 |
PAR-20-127 |
| Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed) |
93.242, 93.855 |
RFA-AI-20-016 |
| NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed) |
93.846 |
RFA-AR-21-003 |
| Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) |
93.173 |
PAR-20-123 |
| NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed) |
93.865 |
PAR-20-126 |
| Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) |
93.121, 93.172, 93.213, 93.233, 93.279, 93.307, 93.313, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.859, 93.866 |
PAR-20-125 |
| Research Education Program Grants for CryoEM and CryoET Curriculum Development (R25 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-010 |
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional) |
93.121, 93.213 |
RFA-AT-21-002 |
| Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional) |
93.121, 93.213 |
RFA-AT-21-001 |
| Urological Epidemiology (UroEpi) Institutional Research Career Development Program (K12 - Independent Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-001 |
| Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) |
93.855 |
PAR-20-120 |
| Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional) |
93.361 |
RFA-NR-20-002 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
PAR-20-122 |
Search Results 2921-2960 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
